HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $151,464 | +79.1% | 1,779 | +65.5% | 0.01% | +66.7% |
| Q4 2022 | $84,549 | -95.1% | 1,075 | -96.7% | 0.01% | -95.7% |
| Q4 2021 | $1,725,000 | +226.7% | 32,535 | +582.9% | 0.14% | +180.0% |
| Q1 2021 | $528,000 | -76.6% | 4,764 | -75.8% | 0.05% | -77.7% |
| Q4 2019 | $2,260,000 | +161.9% | 19,676 | +99.3% | 0.22% | +173.2% |
| Q1 2019 | $863,000 | +323.0% | 9,875 | +382.6% | 0.08% | +310.0% |
| Q4 2018 | $204,000 | +374.4% | 2,046 | +439.8% | 0.02% | +566.7% |
| Q3 2018 | $43,000 | -97.8% | 379 | -98.2% | 0.00% | -97.7% |
| Q2 2018 | $1,916,000 | +1047.3% | 21,375 | +312.6% | 0.13% | +348.3% |
| Q3 2015 | $167,000 | +3240.0% | 5,181 | +3795.5% | 0.03% | +2800.0% |
| Q1 2015 | $5,000 | -97.4% | 133 | -97.8% | 0.00% | -97.8% |
| Q1 2014 | $195,000 | +4775.0% | 6,000 | +5900.0% | 0.05% | +2200.0% |
| Q4 2013 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |